Publication
Coffee and tea consumption, genotype-basedCYP1A2andNAT2activity and colorectal cancer risk-Results from the EPIC cohort study
Coffee and tea consumption and colorectal cancer risk
Vincent K. Dik, H. Bas Bueno-de-Mesquita, Martijn G.H. Van Oijen, Peter D. Siersema, Cuno S.P.M. Uiterwaal, Carla H. Van Gils, Fränzel J.B. Van Duijnhoven, Stéphane Cauchi, Loic Yengo, Philippe Froguel, Kim Overvad, Bodil H. Bech, Anne Tjønneland, Anja Olsen, Marie-Christine Boutron-Ruault, Antoine Racine, Guy Fagherazzi, Tilman Kühn, Daniele Campa, Heiner Boeing, Krasimira Aleksandrova, Antonia Trichopoulou, Eleni Peppa, Eleni Oikonomou, Domenico Palli, Sara Grioni, Paolo Vineis, Rosaria Tumino, Salvatore Panico, Petra H.M. Peeters, Elisabete Weiderpass, Dagrun Engeset, Tonje Braaten, Miren Dorronsoro, María-Dolores Chirlaque, María-José Sánchez, Aurelio Barricarte, Raul Zamora-Ros, Marcial Argüelles, Karin Jirström, Peter Wallström, Lena M. Nilsson, Ingrid Ljuslinder, Ruth C. Travis, Kay-Tee Khaw, Nick Wareham, Heinz Freisling, Idlir Licaj, Mazda Jenab, Marc J. Gunter, Neil Murphy, Dora Romaguera-Bosch, Elio Riboli
International Journal of Cancer, December 2013, Wiley
DOI: 10.1002/ijc.28655